Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Blueprint Medicines Corp shares valued at $512,021 were sold by Albers Jeffrey W. on Mar 05 ’25. At $88.80 per share, Albers Jeffrey W. sold 5,766 shares. The insider’s holdings dropped to 146,630 shares worth approximately $13.27 million following the completion of this transaction.
Also, Albers Jeffrey W. sold 7,500 shares, netting a total of over 658,500 in proceeds. Following the sale of shares at $87.80 each, the insider now holds 152,396 shares.
Before that, Hewes L. Becker had sold 5,232 shares from its account. In a trade valued at $458,804, the CHIEF MEDICAL OFFICER traded Blueprint Medicines Corp shares for $87.69 each. Upon closing the transaction, the insider’s holdings decreased to 5,232 shares, worth approximately $2.75 million.
As published in their initiating research note from Wolfe Research on March 18, 2025, Blueprint Medicines Corp [BPMC] has been an Outperform. Analysts at Jefferies started covering the stock with ‘”a Buy”‘ outlook in a report released in mid March. As of March 07, 2025, Scotiabank has initiated its “Sector outperform” rating for BPMC. Earlier on November 14, 2024, JP Morgan initiated its rating. Their recommendation was “an Overweight” for BPMC stock.
Analyzing BPMC Stock Performance
During the last five days, there has been a drop of approximately -0.02%. Over the course of the year, Blueprint Medicines Corp shares have jumped approximately 3.74%. Shares of the company reached a 52-week high of $118.25 on 01/27/25 and a 52-week low of $84.59 on 03/10/25. A 50-day SMA is recorded $99.09, while a 200-day SMA reached $97.28.
Support And Resistance Levels for Blueprint Medicines Corp (BPMC)
According to the 24-hour chart, there is a support level at 88.97, which, if violated, would cause prices to drop to 87.45. In the upper region, resistance lies at 91.56. The next price resistance is at 92.63. RSI (Relative Strength Index) is 44.67 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.89, which suggests the price will decrease in the coming days. Percent R is at 51.44%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
